CCR1 receptor antagonists for the treatment of U.A. DEMYELINATING INFLAMMATORY DISEASES

摘要

The invention provides compounds having the formula (I): wherein R 1 is halogen. The invention also provides compositions comprising the compounds, and methods of treating diseases or disorders that comprise administering one or more of the compounds to a subject in need thereof. The disclosed compounds have CCR1 antagonist activity.